Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma

• Published in: Genes Vol. 12; no. 6; p. 872
• Main Authors: Chen, Tzu-Ju, Chan, Ti-Chun, Li, Wan-Shan, Li, Chien-Feng, Ke, Hung-Lung, Wei, Yu-Ching, Wu, Wen-Jeng, Li, Wei-Ming
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 06.06.2021; MDPI
• Subjects: Actin; Antibodies; Basement membranes; Bladder cancer; Cancer therapies; Chemotherapy; Clinical outcomes; Cytoskeleton; Data mining; Datasets; Decision making; Disease; EFEMP1; Epidermal growth factor; Extracellular matrix; Gene expression; Immunohistochemistry; Lymph nodes; Lymphatic system; Malignancy; Medical prognosis; Metastases; Metastasis; Mitochondria; Mitosis; Patients; prognosis; Proteins; Software; Statistical analysis; Surgery; Survival; Survival analysis; Tumor microenvironment; Tumors; upper tract urothelial carcinoma; Urinary bladder; Urogenital system; Urothelial carcinoma; United States > US
• DOI: 10.3390/genes12060872
• ISSN: 2073-4425

Urothelial carcinoma (UC) of the upper tract (UTUC) and urinary bladder (UBUC) is a heterogeneous malignancy. Through transcriptomic profiling of the Gene Expression Omnibus UBUC dataset (GSE31684), we discovered that epidermal growth factor-containing fibulin-like extracellularmatrix protein 1 (EFEMP1) was the most upregulated gene during metastatic development. EFEMP1 is an important component of basement membranes and acts as an enzyme regulator in extracellular matrix biology. Initially, evaluation of EFEMP1 mRNA expression in 50 UBUCs showed significantly upregulated levels in high stage UC. We further validated the clinical significance of EFEMP1 in 340 UTUC and 295 UBUC using immunohistochemistry, evaluated by H-score. High EFEMP1 immunoexpression significantly correlated with high pathologic stage, high histological grade, lymph node metastasis, vascular invasion, perineural invasion and high mitosis (all p < 0.05). After adjusting for established clinicopathological factors, EFEMP1 expression status retained its prognostic impact on disease-specific survival and metastasis-free survival in UTUC and UBUC (all p < 0.01). Furthermore, Ingenuity Pathway Analysis showed that actin cytoskeleton signaling, tumor microenvironment pathway and mitochondrial dysfunction were significantly enriched by EFEMP1 dysregulation. In conclusion, high EFEMP1 expression was associated with adverse pathological features in UC and independently predicted worse outcomes, suggesting its roles in clinical decision-making and risk stratification.